NCT01841736 2026-03-18Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting171 enrolled 15 charts
NCT06959641 2025-06-11XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid CancerNorthwestern UniversityPhase 2 Recruiting33 enrolled